prikaz prve stranice dokumenta Dexamethasone treatment for COVID-19 is related to increased mortality in hematologic malignancy patients: results from the EPICOVIDEHA Registry
Rad je dostupan svim korisnicima iz sustava znanosti i visokog obrazovanja RH
Znanstveni rad - Pismo
Dexamethasone treatment for COVID-19 is related to increased mortality in hematologic malignancy patients: results from the EPICOVIDEHA Registry
Haematologica, 109 (2024), 8; 2693-2700. https://doi.org/10.3324/haematol.2023.284678
(EPICOVIDEHA) Aiello, TF; Salmanton-Garcia, J; ...; ...; Valković, Toni; ...; ...

Citirajte ovaj rad

Aiello, T., Salmanton Garcia, J. i Valković, T. (2024). Dexamethasone treatment for COVID-19 is related to increased mortality in hematologic malignancy patients: results from the EPICOVIDEHA Registry. Haematologica, 109. (8), 2693-2700. doi: 10.3324/haematol.2023.284678

Aiello, TF, et al. "Dexamethasone treatment for COVID-19 is related to increased mortality in hematologic malignancy patients: results from the EPICOVIDEHA Registry." Haematologica, vol. 109, br. 8, 2024, str. 2693-2700. https://doi.org/10.3324/haematol.2023.284678

Aiello, TF, J Salmanton Garcia i Toni Valković. "Dexamethasone treatment for COVID-19 is related to increased mortality in hematologic malignancy patients: results from the EPICOVIDEHA Registry." Haematologica 109, br. 8 (2024): 2693-2700. https://doi.org/10.3324/haematol.2023.284678

Aiello, T., Salmanton Garcia, J. i Valković, T. (2024) 'Dexamethasone treatment for COVID-19 is related to increased mortality in hematologic malignancy patients: results from the EPICOVIDEHA Registry', Haematologica, 109(8), str. 2693-2700. doi: 10.3324/haematol.2023.284678

Aiello T, Salmanton Garcia J, Valković T. Dexamethasone treatment for COVID-19 is related to increased mortality in hematologic malignancy patients: results from the EPICOVIDEHA Registry. Haematologica [Internet]. 04.04.2024. [pristupljeno 05.12.2024.];109(8):2693-2700. doi: 10.3324/haematol.2023.284678

T. Aiello, J. Salmanton Garcia i T. Valković, "Dexamethasone treatment for COVID-19 is related to increased mortality in hematologic malignancy patients: results from the EPICOVIDEHA Registry", Haematologica, vol. 109, br. 8, str. 2693-2700, Travanj 2024. [Online]. Dostupno na: https://urn.nsk.hr/urn:nbn:hr:184:437967. [Citirano: 05.12.2024.]

Za citiranje koristite ovu mrežnu adresu: https://urn.nsk.hr/urn:nbn:hr:184:437967
Prijavite se u repozitorij kako biste mogli spremiti objekt u svoju listu.
Podaci o radu
Naslov (engleski)Dexamethasone treatment for COVID-19 is related to increased mortality in hematologic malignancy patients: results from the EPICOVIDEHA Registry
AutorTF Aiello
AutorJ Salmanton-Garcia
Autor
...
Autor
...
AutorToni Valković
Autor
...
Autor
...
KolaboracijaEPICOVIDEHA
Autorova ustanovaSveučilište u Rijeci
Medicinski fakultet
(Katedra za internu medicinu)
Znanstveno / umjetničko
područje, polje i grana		BIOMEDICINA I ZDRAVSTVO
Kliničke medicinske znanosti
Interna medicina
Jezikengleski
Vrsta publikacijeZnanstveni rad - Pismo
Status objaveObjavljen
Vrsta recenzijeRecenziran - međunarodna recenzija
Verzija publikacijeObjavljena verzija rada (izdavačev PDF)
Naslov časopisaHaematologica
Brojčani podacivol. 109, br. 8, str. 2693-2700
p-ISSN0390-6078
e-ISSN1592-8721
DOIhttps://doi.org/10.3324/haematol.2023.284678
URN:NBNurn:nbn:hr:184:437967
Datum objave publikacije2024-04-04
URL dokumentahttps://haematologica.org/article/view/haematol.2023.284678
Vrsta resursaTekst
Prava pristupaOgraničen pristup
Uvjeti korištenjaIkona licence Zaštićeno autorskim pravom.
Datum i vrijeme pohrane2024-08-23 08:39:42